These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Characterization of the conformational state and flexibility of HIV-1 glycoprotein gp120 core domain. Pan Y; Ma B; Keskin O; Nussinov R J Biol Chem; 2004 Jul; 279(29):30523-30. PubMed ID: 15131118 [TBL] [Abstract][Full Text] [Related]
63. Resistance of primary isolates of human immunodeficiency virus type 1 to neutralization by soluble CD4 is not due to lower affinity with the viral envelope glycoprotein gp120. Turner S; Tizard R; DeMarinis J; Pepinsky RB; Zullo J; Schooley R; Fisher R Proc Natl Acad Sci U S A; 1992 Feb; 89(4):1335-9. PubMed ID: 1741386 [TBL] [Abstract][Full Text] [Related]
64. Effects of the I559P gp41 change on the conformation and function of the human immunodeficiency virus (HIV-1) membrane envelope glycoprotein trimer. Alsahafi N; Debbeche O; Sodroski J; Finzi A PLoS One; 2015; 10(4):e0122111. PubMed ID: 25849367 [TBL] [Abstract][Full Text] [Related]
65. Protein-disulfide isomerase-mediated reduction of two disulfide bonds of HIV envelope glycoprotein 120 occurs post-CXCR4 binding and is required for fusion. Barbouche R; Miquelis R; Jones IM; Fenouillet E J Biol Chem; 2003 Jan; 278(5):3131-6. PubMed ID: 12218052 [TBL] [Abstract][Full Text] [Related]
66. Lack of correlation between soluble CD4-induced shedding of the human immunodeficiency virus type 1 exterior envelope glycoprotein and subsequent membrane fusion events. Thali M; Furman C; Helseth E; Repke H; Sodroski J J Virol; 1992 Sep; 66(9):5516-24. PubMed ID: 1501286 [TBL] [Abstract][Full Text] [Related]
67. Statistical properties of thermodynamic quantities for cyclodextrin complex formation. Burnette RR; Connors KA J Pharm Sci; 2000 Nov; 89(11):1389-94. PubMed ID: 11015684 [TBL] [Abstract][Full Text] [Related]
68. Flexibility of small molecular CD4 mimics as HIV entry inhibitors. Kobayakawa T; Ohashi N; Hirota Y; Takahashi K; Yamada Y; Narumi T; Yoshimura K; Matsushita S; Harada S; Tamamura H Bioorg Med Chem; 2018 Nov; 26(21):5664-5671. PubMed ID: 30366786 [TBL] [Abstract][Full Text] [Related]
69. Bacterially expressed HIV-1 gp120 outer-domain fragment immunogens with improved stability and affinity for CD4-binding site neutralizing antibodies. Rathore U; Purwar M; Vignesh VS; Das R; Kumar AA; Bhattacharyya S; Arendt H; DeStefano J; Wilson A; Parks C; La Branche CC; Montefiori DC; Varadarajan R J Biol Chem; 2018 Sep; 293(39):15002-15020. PubMed ID: 30093409 [TBL] [Abstract][Full Text] [Related]
72. Lineage-Specific Differences between the gp120 Inner Domain Layer 3 of Human Immunodeficiency Virus and That of Simian Immunodeficiency Virus. Ding S; Medjahed H; Prévost J; Coutu M; Xiang SH; Finzi A J Virol; 2016 Nov; 90(22):10065-10073. PubMed ID: 27535053 [TBL] [Abstract][Full Text] [Related]
73. The molecular mechanism of two coreceptor binding site antibodies X5 and 17b neutralizing HIV-1: Insights from molecular dynamics simulation. Zhang Y; Guo J; Huang L; Tian J; Yao X; Liu H Chem Biol Drug Des; 2018 Jul; 92(1):1357-1365. PubMed ID: 29624884 [TBL] [Abstract][Full Text] [Related]
74. Inhibitors of the conformational switch involved in CD4 binding by the env glycoprotein gp120 from human immunodeficiency virus type 1 (HIV1). Reed J; Kinzel V Biochemistry; 1994 Sep; 33(36):10993-8. PubMed ID: 8086417 [TBL] [Abstract][Full Text] [Related]
76. Generative models of conformational dynamics. Langmead CJ Adv Exp Med Biol; 2014; 805():87-105. PubMed ID: 24446358 [TBL] [Abstract][Full Text] [Related]
77. How much binding affinity can be gained by filling a cavity? Kawasaki Y; Chufan EE; Lafont V; Hidaka K; Kiso Y; Mario Amzel L; Freire E Chem Biol Drug Des; 2010 Feb; 75(2):143-51. PubMed ID: 20028396 [TBL] [Abstract][Full Text] [Related]
78. Thermodynamics of ligand binding and efficiency. Reynolds CH; Holloway MK ACS Med Chem Lett; 2011 Jun; 2(6):433-7. PubMed ID: 24900326 [TBL] [Abstract][Full Text] [Related]
79. Thermodynamics-based drug design: strategies for inhibiting protein-protein interactions. Schön A; Lam SY; Freire E Future Med Chem; 2011 Jul; 3(9):1129-37. PubMed ID: 21806377 [TBL] [Abstract][Full Text] [Related]